Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akero Therapeutics

50.51
-1.3100-2.53%
Post-market: 50.510.00000.00%18:37 EDT
Volume:1.01M
Turnover:50.99M
Market Cap:4.03B
PE:-13.49
High:52.05
Open:51.97
Low:50.38
Close:51.82
Loading ...
Feb 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Major Issues Report

8-K - Current report
Nov 16, 2020

Major Issues Report

8-K - Current report
Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2020

Major Issues Report

8-K - Current report
Oct 15, 2020

Major Issues Report

8-K - Current report
Sep 10, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 09, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2020

Major Issues Report

8-K - Current report
Jul 14, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 08, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 07, 2020

Major Issues Report

8-K/A [Amend] - Current report
Jul 06, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jul 06, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jul 06, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jun 30, 2020

Major Issues Report

8-K - Current report
Jun 17, 2020

Major Issues Report

8-K - Current report